Next Article in Journal
An Extremely Rare Case of Disseminated Peritoneal Leiomyomatosis with a Pelvic Leiomyosarcoma and Omental Metastasis after Laparoscopic Morcellation: Systematic Review of the Literature
Previous Article in Journal
Image Fusion Involving Real-Time Transabdominal or Endoscopic Ultrasound for Gastrointestinal Malignancies: Review of Current and Future Applications
 
 
Review
Peer-Review Record

Chronic Active T-Cell Mediated Kidney Rejection as a Clinically Significant Type of Allograft Loss?

Diagnostics 2022, 12(12), 3220; https://doi.org/10.3390/diagnostics12123220
by Jakub Mizera 1,2,*,†, Justyna Pilch 1,2,†, Dorota Kamińska 1, Magdalena Krajewska 1, Piotr Donizy 2,‡ and Mirosław Banasik 1,‡
Reviewer 1:
Reviewer 2:
Diagnostics 2022, 12(12), 3220; https://doi.org/10.3390/diagnostics12123220
Submission received: 22 November 2022 / Revised: 14 December 2022 / Accepted: 16 December 2022 / Published: 19 December 2022
(This article belongs to the Section Pathology and Molecular Diagnostics)

Round 1

Reviewer 1 Report

The article describes in great details a very important clinical
problem regarding the rejection of chronic active (CA) T-13 cell mediated rejection (TCMR) of a kidney. The manuscript was prepared, perferctly.
The aims of the work, the exclusion criteria were presented in details.
The discussion has been prepared very clearly, too.
In addition, the article contains a lot of necessary clinical information
for transplantologists, who work with patients after kidney transplantation.
Finally, the manuscript shows the high scientific level of all authors.

 

Author Response

Dear Mr./Mrs.,

We sincerely appreciate your review, remarks and time dedicated to our work.

Best regards,

Jakub Mizera

Reviewer 2 Report

Jakub Mizera et al. reviewed the CA TCMR criteria, diagnosis and treatment. Overall, it is a good review.

I have a suggestion, in the molecular diagnosis section, the immune repertoire can be added. Recently, TCR and BCR detection using NGS can provide us the T and B cells clone information. It also give us an immune diversity map. It is very helpful for different kinds of rejection diagnosis.

Author Response

Dear Mr./Mrs.

We sincerely appreciate your review, remarks and time dedicated to our work. We applied your suggestions and included (in the Molecular Diagnostics section) the paragraph regarding NGS role in clinical management and prediction of graft failure in patients after kidney transplantation.

Best regards, 

Jakub Mizera

Back to TopTop